Modeling drug resistance in a conjoint normal-tumor setting

Area of Science:

• Mathematical Biology
• Computational Oncology
• Cancer Research

Background:

• Previously developed a conjoint tumor-normal cell model.
• Modified the model to differentiate chemotherapy-responsive and resistant tumor cells.

Purpose of the Study:

• To analyze the evolution of normal, tumor, and drug-resistant tumor cells.
• To identify critical factors influencing cell dynamics during cancer progression and treatment.

Main Methods:

• Utilized a modified conjoint tumor-normal cell model.
• Conducted numerical simulations to study cell evolution.
• Investigated the impact of various treatment parameters.

Main Results:

• Demonstrated the evolution of three distinct cell populations: normal, tumor, and drug-resistant tumor cells.
• Identified key factors influencing cell dynamics, including cell co-dependency and treatment strategies.
• Illustrated how drug response mechanisms, administration sequences, and timing affect cell evolution.

Conclusions:

• Enhanced understanding of normal, drug-responsive, and drug-resistant tumor cell evolution during cancer progression.
• Provides insights for improving therapeutic strategies in cancer treatment.